Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients

Mesenchymal stem cells (MSCs) are optimal sources of autologous stem cells for cell-based therapy in chronic kidney disease (CKD). However, CKD-associated pathophysiological conditions, such as endoplasmic reticulum (ER) stress and oxidative stress, decrease MSC function. In this work, we study the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Yeo Min, Lee, Jun Hee, Yun, Chul Won, Lee, Sang Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540009/
https://www.ncbi.nlm.nih.gov/pubmed/31083336
http://dx.doi.org/10.3390/ijms20092314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540009/
https://www.ncbi.nlm.nih.gov/pubmed/31083336
http://dx.doi.org/10.3390/ijms20092314

Ejemplares similares